KR830004332A - 린코마이신 및 클린다마이신의 제조방법 - Google Patents
린코마이신 및 클린다마이신의 제조방법 Download PDFInfo
- Publication number
- KR830004332A KR830004332A KR1019800004298A KR800004298A KR830004332A KR 830004332 A KR830004332 A KR 830004332A KR 1019800004298 A KR1019800004298 A KR 1019800004298A KR 800004298 A KR800004298 A KR 800004298A KR 830004332 A KR830004332 A KR 830004332A
- Authority
- KR
- South Korea
- Prior art keywords
- thio
- methyl
- rincosamide
- substituted
- formula
- Prior art date
Links
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 title 1
- 229960002227 clindamycin Drugs 0.000 title 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 title 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 title 1
- 229960005287 lincomycin Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 150000001408 amides Chemical class 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 238000010531 catalytic reduction reaction Methods 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 150000002829 nitrogen Chemical class 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 150000002926 oxygen Chemical class 0.000 claims 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C07H15/16—Lincomycin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 구조식(Ⅰ)의 화합물을 제조하는 방법,구조식(Ⅲ)의 화합물을 제조하는 방법,구조식(Ⅴ)의 화합물을 제조하는 방법 및구조식(Ⅷ)의 화합물을 제조하는 방법.상기 구조식(I)에서 R1은 치환기 R2에 의해 이미 치환되지 않은 피리딘의 어느 위치에나 단일 또는 다중으로 치환될 수 있는 것으로서 수소, 알킬, 알킬부분의 탄소수가 1-8인 치환알킬, 치환알킬의 이성체들, 시클로알킬, 치환 시클로 알킬, 치환산소, 치환 질소, 할로겐, 페닐, 치환페닐, n이 1-8인-(CH2)n-OH, -(OH2)n-NR4R5및 그들의 이성체 들로 이루어진 기중에서 선택된다. 상기식에서 R4및 R5는 수소나 탄소수 1-8인 알킬 및 그들의 이성체이다. 한편 R2는 R1에 의해 이미 치환되지 않은 피리딘의 어느 부분에나 단일 치환될 수 있으며이다.여기서 X는 7(R)-하이드록시-메틸-1-티오-α-린코스아미니드, 7(S)-하이드록시-메틸-1-티오-α-린코스아미니드, 7(S)-할로-메틸-1-티오-α-린코스아미니드, 7(R)-할로-메틸-1-티오-α-린코스아미니드, 7(S)-메톡시-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(메틸티오)-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(2-하이드록시 에틸티오)-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(3-하이드록시 프로필티오)-메틸-1-티오-α-린코스아미니드 및 이들의 제약상 가능한 그들의 산부가염 들로 구성된 군중에서 선택된 화합물의 아미노기이다.상기식(Ⅲ)에서 R1및 R2는 링상의 2,3,4,5,6,7,5,9 위치에 단일 또는 다중 치환될 수 있는 것으로서, 수소, 알킬, 알킬 부분의 탄소수가 1-8인 치환알킬, 치환알킬의 이성체들, 시클로 알킬, 치환 시클로 알킬, 치환 산소, 치환 질소, 할로겐, 페닐, 치환페닐, n이 1-8인 -(CH2)n -0H, -(CH2)n -NR4R5및 그들의 이성체들로 이루어진 기중에서 선택된다.한편 R2는 R1에 의해 이미 치환되지 않은 피리딘의 어느 부분에나 단일 치환될수 있으며이다.여기서 X는 7(R)-하이드록시-메틸-1-티오-α-린코스아미니드, 7(S)-하이드록시-메틸-1-티오-α-린코스아미니드, 7(S)-할로-메틸-1-티오-α-린코스아미니드, 7(R)-할로-메틸-티오-1-α-린코스 아미니드, 7(S)-메톡시-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(메틸티오)-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(2-하이드록시에틸티오)-메틸-1-티오-α-린코스아미니드 및 7-데옥시-7(S)-(3-하이드록시 프로필티오)-메틸-1-티오-α-린코스아미니드들로 구성된 기중에서 선택된 화합물의 아미노기이다.R3는 H, CH3, C2H5및 -CH2-CH2-OH 중하나이며, n은 1-4이다.상기 화합물(Ⅲ)은 다음 구조식의 아미노산과의 반응을 포함한다.여기서, R1은 위에서 정의된 바와 같고,기는 R1에 의해 이미 치환되지 않은 피리딘 링상의 어느 위치에나 치환가능하며, R3는 7(R)-하이드록시-메틸-1-티오-α-린코스아미니드, 7(S)-하이드록시-메틸-1-티오-α-린코스아미니드, 7(S)-할로-메틸-1-티오-α-린코스아미니드, 7(R)-할로-메틸-1-티오-α-린코스 아미니드, 7(S)-메톡시-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(메틸티오)-메틸-1-티오-α-린코스 아미니드, 7-데옥시-7-(S)-(2-하이드록시에틸티오)-메틸-1-티오-α-린코스아미니드 및 7-데옥시-7(S)-(3-하이드록시프로필티오)-메틸-1-티오-α-린코스아미니드, 7-데옥시-7(S)-(3-하이드록시프로필티오)-메틸-1-티오-α-린코스아미니드로 구성된 기중에서 선택된 화합물을 함유하며 위에서 정의된 바와 같다.상기 구조식(Ⅴ)의 화합물은 아래 구조식의 화합물의 촉매 환원 반응을 포함한다.여기서 R1은 에틸이며, X는 7(S)-클로로-메틸-1-티오-α-린코스아미니드이다.상기 구조식(Ⅷ)의 화합물은 아래 구조식의 화합물의 촉매 환원반응을 포함한다.여기서 R1은 부틸이며, X는 7(S)-클로로-메틸-1-티오-α-린코스아미니드이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9665279A | 1979-11-23 | 1979-11-23 | |
US96652 | 1979-11-23 | ||
US06/148,056 US4278789A (en) | 1979-11-23 | 1980-05-19 | Lincomycin compounds |
US148056 | 1980-05-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830004332A true KR830004332A (ko) | 1983-07-09 |
KR850000065B1 KR850000065B1 (ko) | 1985-02-15 |
Family
ID=26791923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019800004298A KR850000065B1 (ko) | 1979-11-23 | 1980-11-08 | 린코마이신 및 클린다마이신의 제조방법 |
Country Status (16)
Country | Link |
---|---|
US (1) | US4278789A (ko) |
KR (1) | KR850000065B1 (ko) |
AU (1) | AU535986B2 (ko) |
CA (1) | CA1165315A (ko) |
CH (1) | CH647244A5 (ko) |
DE (1) | DE3043502A1 (ko) |
ES (1) | ES8204442A1 (ko) |
FR (4) | FR2470134B1 (ko) |
GB (1) | GB2063252B (ko) |
HU (2) | HU187281B (ko) |
IL (1) | IL61245A (ko) |
IT (1) | IT1134065B (ko) |
NL (2) | NL194240C (ko) |
PL (2) | PL132002B1 (ko) |
SE (1) | SE447260B (ko) |
SU (1) | SU1169543A3 (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4368193A (en) * | 1981-04-20 | 1983-01-11 | The Upjohn Company | Process for treating malaria |
US4383109A (en) * | 1981-04-20 | 1983-05-10 | The Upjohn Company | Lincomycin nucleotides |
US4393054A (en) * | 1982-05-19 | 1983-07-12 | The Upjohn Company | Method of treating cardiac arrhythmia |
US4430495A (en) | 1982-09-17 | 1984-02-07 | The Upjohn Company | Process for preparing lincomycin and clindamycin ribonucleotides |
EP0362232B1 (en) * | 1987-05-19 | 1991-11-06 | The Upjohn Company | Pirlimycin growth enhancers for meat producing animals |
TW282399B (ko) * | 1990-05-25 | 1996-08-01 | Takeda Pharm Industry Co Ltd | |
CA2445591A1 (en) * | 2001-04-27 | 2002-11-07 | The Procter & Gamble Company | Nitrogen heterocyclic compounds and compositions for controlling biofilms |
ATE337777T1 (de) * | 2001-06-15 | 2006-09-15 | Innovent Technology Ltd | Zusammensetzung zur behandlung von huf- und klauenerkrankungen |
BR0212214A (pt) * | 2001-08-28 | 2004-10-19 | Pharmacia Corp | Base livre de clindamicina cristalina |
CA2493799A1 (en) * | 2002-08-15 | 2004-02-26 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
US7199105B2 (en) * | 2002-08-15 | 2007-04-03 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
WO2005012320A2 (en) * | 2003-06-17 | 2005-02-10 | Vicuron Pharmaceuticals, Inc. | Novel lincomycin derivatives possessing antimicrobial activity |
US7256177B2 (en) | 2003-06-17 | 2007-08-14 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
US7199106B2 (en) | 2003-06-17 | 2007-04-03 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antimicrobial activity |
US7361743B2 (en) * | 2004-02-11 | 2008-04-22 | Pfizer Inc | Lincomycin derivatives possessing antibacterial activity |
CN100404543C (zh) * | 2006-09-21 | 2008-07-23 | 浙江海正药业股份有限公司 | 一种合成吡利霉素的中间体及其制备方法和用途 |
EP2809156B1 (en) * | 2011-12-08 | 2017-05-24 | The Board of Regents of The University of Texas System | Allosteric modulators of 5-hydroxytryptamine 2c receptor (5-ht2cr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3086912A (en) * | 1961-07-03 | 1963-04-23 | Upjohn Co | Antibiotic lincolnensin and method of production |
US3496163A (en) * | 1965-02-08 | 1970-02-17 | Upjohn Co | 7-halo-7-deoxylincomycins and process for preparing the same |
US3758454A (en) * | 1971-03-12 | 1973-09-11 | Upjohn Co | Lincomycin type compounds and process for making them |
US3853843A (en) * | 1972-12-13 | 1974-12-10 | Upjohn Co | Derivatives of thiolincosaminide compounds |
-
1980
- 1980-05-19 US US06/148,056 patent/US4278789A/en not_active Expired - Lifetime
- 1980-10-10 IL IL61245A patent/IL61245A/xx not_active IP Right Cessation
- 1980-10-16 CA CA000362485A patent/CA1165315A/en not_active Expired
- 1980-10-16 AU AU63443/80A patent/AU535986B2/en not_active Expired
- 1980-10-20 GB GB8033726A patent/GB2063252B/en not_active Expired
- 1980-10-27 IT IT25607/80A patent/IT1134065B/it active
- 1980-11-08 KR KR1019800004298A patent/KR850000065B1/ko active
- 1980-11-14 NL NL8006229A patent/NL194240C/nl active Protection Beyond IP Right Term
- 1980-11-18 DE DE19803043502 patent/DE3043502A1/de active Granted
- 1980-11-19 ES ES496988A patent/ES8204442A1/es not_active Expired
- 1980-11-21 HU HU802786A patent/HU187281B/hu not_active IP Right Cessation
- 1980-11-21 FR FR808024823A patent/FR2470134B1/fr not_active Expired
- 1980-11-21 CH CH8629/80A patent/CH647244A5/de not_active IP Right Cessation
- 1980-11-21 HU HU83317A patent/HU190437B/hu not_active IP Right Cessation
- 1980-11-21 SE SE8008181A patent/SE447260B/sv not_active IP Right Cessation
- 1980-11-24 PL PL1980233258A patent/PL132002B1/pl unknown
- 1980-11-24 PL PL22805480A patent/PL228054A1/xx unknown
-
1981
- 1981-07-09 FR FR8113543A patent/FR2493852B1/fr not_active Expired
- 1981-07-09 FR FR8113537A patent/FR2487358A1/fr active Pending
- 1981-07-09 FR FR8113542A patent/FR2491072A1/fr active Pending
- 1981-08-19 SU SU813444858A patent/SU1169543A3/ru active
-
2001
- 2001-10-02 NL NL300064C patent/NL300064I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
CA1165315A (en) | 1984-04-10 |
GB2063252A (en) | 1981-06-03 |
FR2470134B1 (fr) | 1985-07-26 |
FR2491072A1 (fr) | 1982-04-02 |
NL300064I2 (nl) | 2002-01-02 |
NL8006229A (nl) | 1981-06-16 |
FR2487358A1 (fr) | 1982-01-29 |
ES496988A0 (es) | 1982-05-01 |
SE447260B (sv) | 1986-11-03 |
NL194240C (nl) | 2001-10-02 |
FR2470134A1 (fr) | 1981-05-29 |
IL61245A0 (en) | 1980-12-31 |
HU187281B (en) | 1985-12-28 |
NL300064I1 (nl) | 2001-12-01 |
PL233258A1 (en) | 1983-05-09 |
HU190437B (en) | 1986-09-29 |
DE3043502C2 (ko) | 1989-05-11 |
PL228054A1 (en) | 1983-05-09 |
AU6344380A (en) | 1981-05-28 |
ES8204442A1 (es) | 1982-05-01 |
IT8025607A0 (it) | 1980-10-27 |
IL61245A (en) | 1986-07-31 |
PL132002B1 (en) | 1985-01-31 |
GB2063252B (en) | 1983-05-18 |
CH647244A5 (de) | 1985-01-15 |
DE3043502A1 (de) | 1981-06-04 |
FR2493852B1 (fr) | 1985-08-16 |
KR850000065B1 (ko) | 1985-02-15 |
SE8008181L (sv) | 1981-05-24 |
US4278789A (en) | 1981-07-14 |
NL194240B (nl) | 2001-06-01 |
FR2493852A1 (fr) | 1982-05-14 |
AU535986B2 (en) | 1984-04-12 |
IT1134065B (it) | 1986-07-24 |
SU1169543A3 (ru) | 1985-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830004332A (ko) | 린코마이신 및 클린다마이신의 제조방법 | |
DE69012515D1 (de) | Haarfärbemittel. | |
KR860009023A (ko) | 치환된 실릴기를 갖는 신규 에테르 화합물의 제조방법 | |
CA2070663A1 (en) | Sulfonating agent and process | |
KR840006482A (ko) | 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법 | |
ES2000061A6 (es) | Procedimiento para la preparacion de esteres de hidroxiacidos dicarboxilicos | |
ATE113280T1 (de) | Eine perfluoralkylgruppe enthaltende verbindung. | |
CA2130618A1 (en) | Stereoselective process for preparing .beta.-anomer enriched 2-deoxy-2,2-difluoro-d-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonate intermediates | |
KR840005717A (ko) | 벤즈아미드 유도체의 제조방법 | |
EP0083204A3 (en) | 2-aminophenol derivatives and process for their preparation | |
KR910000638A (ko) | 피롤카르복시산 유도체 | |
KR890013008A (ko) | 아졸일메틸옥시란 및 이들을 함유하는 살균제 | |
KR840005107A (ko) | 피리미디온 및 그의 산부가염의 제조방법 | |
BR8603787A (pt) | Compostos heterociclicos,e,processo de sua preparacao e aplicacao | |
AU551839B2 (en) | Imidazolylcarboxylic acids and derivative | |
JPS55111492A (en) | Thiazole derivative and its manufacture | |
KR860006461A (ko) | 항알레르기 작용을 갖는 화합물의 제조방법 | |
PT93285A (pt) | Processo para a preparacao de derivados lactamicos | |
KR830007509A (ko) | 아미노산 유도체의 제조방법 | |
ES2061864T3 (es) | Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene. | |
KR860008184A (ko) | 디옥솔로벤조이소옥사졸 유도체의 제법 | |
ES529838A0 (es) | Procedimiento para la preparacion de agentes biocidas | |
GB1336442A (en) | Preparation of adenosine-3,5-monophosphoric acid derivatives | |
KR850003413A (ko) | 1,3-디티올-2-일리덴-말론산에스테르 유도체의 제조방법 | |
KR880000403A (ko) | 신규한 살균제 제조방법 |